Filter posts

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual …

2012 BIO Convention in China: Highlighting Cross-Border Partnering in Biotechnology

In its second year, the BIO Convention in China will be held October 24-25, 2012 …

Five Keys to Making Biotech Flourish in China

As China positions itself as a major global player in the international biotechnology arena, it …

International Programming Highlights

For those looking to take advantage of all the Convention has to offer, specifically within …

Fall Preview: Business Development Events

Now that the Business Forum and International Convention are behind us, our Business Development department …

International groups put the “International” in BIO International Convention

The international presence at the global event for biotechnology was in full-force this year, with …

Scientific American on BRIC's IP Environment

Scientific American World View issued a special report at this year’s 2011 BIO International Convention …

Innovative China: Policies for the Future

As the second largest and fastest growing market for biotechnology products, China needs no introduction.  …

The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the BIO International …